Bruker Corporation
General ticker "BRKR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $8.6B
Bruker Corporation does not follow the US Stock Market performance with the rate: -16.0%.
Estimated limits based on current volatility of 1.9%: low 55.37$, high 57.50$
Factors to consider:
- Company pays dividends: last record date 2024-12-02, amount 0.05$ (Y0.35%)
- China accounted for 15.7% of revenue in the fiscal year ended 2022-12-31
- US accounted for 27.5% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [61.77$, 88.32$]
- 2024-12-30 to 2025-12-30 estimated range: [65.75$, 94.38$]
Financial Metrics affecting the BRKR estimates:
- Positive: Non-GAAP EPS, $ of 2.58 > 2.29
- Positive: 9.05 < Operating profit margin, % of 14.74
- Positive: Interest expense per share, $ of 0.11 <= 0.14
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: 2.35 < Operating cash flow per share per price, % of 3.44
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
Short-term BRKR quotes
Long-term BRKR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,417.90MM | $2,530.70MM | $2,964.50MM |
| Operating Expenses | $2,004.60MM | $2,098.00MM | $2,527.60MM |
| Operating Income | $413.30MM | $432.70MM | $436.90MM |
| Non-Operating Income | $-19.70MM | $-18.80MM | $107.30MM |
| Interest Expense | $14.30MM | $16.10MM | $16.40MM |
| R&D Expense | $220.80MM | $235.90MM | $294.80MM |
| Income(Loss) | $393.60MM | $413.90MM | $544.20MM |
| Taxes | $113.00MM | $117.30MM | $117.00MM |
| Profit(Loss) | $280.60MM | $296.60MM | $427.20MM |
| Stockholders Equity | $1,084.60MM | $1,125.70MM | $1,377.20MM |
| Inventory | $710.10MM | $803.70MM | $968.30MM |
| Assets | $3,650.00MM | $3,618.50MM | $4,249.90MM |
| Operating Cash Flow | $282.40MM | $262.00MM | $350.10MM |
| Capital expenditure | $92.00MM | $119.00MM | $106.90MM |
| Investing Cash Flow | $-192.40MM | $-239.30MM | $-326.00MM |
| Financing Cash Flow | $318.70MM | $-415.20MM | $-193.40MM |
| Earnings Per Share* | $1.83 | $2.00 | $2.92 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.